|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12N 15/10 | (2006.01) |
| C12N 15/63 | (2006.01) | ||
| C12N 9/22 | (2006.01) |
| (11) | Number of the document | 3360964 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18156734.8 |
| Date of filing the European patent application | 2013-12-05 | |
| (97) | Date of publication of the European application | 2018-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-02 |
| (46) | Date of publication of the claims translation | 2019-12-27 |
| (30) | Number | Date | Country code |
| 201261734256 P | 2012-12-06 | US | |
| 201361758624 P | 2013-01-30 | US | |
| 201361761046 P | 2013-02-05 | US | |
| 201361794422 P | 2013-03-15 | US |
| (72) |
Chen, Fuqiang, US
Davis, Gregory D., US
|
| (73) |
Sigma-Aldrich Co. LLC,
3050 Spruce Street, St. Louis, MO 63103,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | CRISPR grindžiamas genomo modifikavimas ir reguliavimas |
| CRISPR-BASED GENOME MODIFICATION AND REGULATION |
| Payment date | Validity (years) | Amount | |
| 2024-10-25 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-11-12 |